A MULTI-CENTER, DOUBLE-BLIND, RANDOMIZED, PARALLEL-GROUP STUDY OF THE EFFICACY AND SAFETY OF TWO LENALIDOMIDE DOSE REGIMENS IN SUBJECTS WITH RELAPSED OR REFRACTORY B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA

Update Il y a 4 ans
Reference: EUCTR2006-004469-32

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

To evaluate the efficacy of two dose regimens of lenalidomide in subjects with relapsed or refractory B-cell chronic lymphocytic leukemia (CLL)


Inclusion criteria

  • For the treatment of relapsed or refractory B-CLL